N-[(1-methyl-1H-1,3-benzodiazol-2-yl)(phenyl)methyl]prop-2-enamide
Structure Info
- Chemspace ID
- CSSB02077547457 (In-Stock Building Blocks)
- IUPAC Name
- N-[(1-methyl-1H-1,3-benzodiazol-2-yl)(phenyl)methyl]prop-2-enamide
- Mol formula
- C18H17N3O
- Mol weight
- 291 Da
- Catalog Number(s)
- BBLS02077547457, CSC107727076, CSCR00107727076, EN300-54547704, Z1938042865, bbls02077547457, m273270____12886636____10884640
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 3.19
- Heavy atoms count
- 22
- Rotatable bond count
- 4
- Number of rings
- 3
- Carbon bond saturation, Fsp3
- 0.111
- Polar surface area (Å)
- 47
- Hydrogen bond acceptors count
- 2
- Hydrogen bond donors count
- 1
![Chemical structure of N-[(1-methyl-1H-1,3-benzodiazol-2-yl)(phenyl)methyl]prop-2-enamide (C18H17N3O) - CSSB02077547457](/st/structure/200/cb4f51d7aed86b4be49b01f437595ffd/C%253DCC%2528%253DO%2529NC%2528C1%253DCC%253DCC%253DC1%2529C1%253DNC2%253DCC%253DCC%253DC2N1C.png "C18H17N3O")
- Zoom the structure
- CSSB02077547457
Items Overall 8 items from 1 supplier
| Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
|---|---|---|---|---|---|---|
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 50 mg | 455.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 100 mg | 477.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 250 mg | 498.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 500 mg | 519.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 1 g | 541.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 2.5 g | 1,063.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 5 g | 1,572.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 10 g | 2,331.00 |
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire
Similarity Analogs
![Chemical structure of N-[1-(1-methyl-1H-1,3-benzodiazol-2-yl)ethyl]prop-2-enamide - CSSB00103370289](/st/structure/200/6bc12c526428a1abd32a2cb62c8435f3/CC%2528NC%2528%253DO%2529C%253DC%2529C1%253DNC2%253DCC%253DCC%253DC2N1C.png)
![Chemical structure of 2-chloro-2-fluoro-N-[(1-methyl-1H-1,3-benzodiazol-2-yl)(phenyl)methyl]acetamide - CSSB21332116490](/st/structure/200/e34f215f405ea055ecb91418d2751415/CN1C%2528%253DNC2%253DC1C%253DCC%253DC2%2529C%2528NC%2528%253DO%2529C%2528F%2529Cl%2529C1%253DCC%253DCC%253DC1.png)
![Chemical structure of 2-chloro-N-[(1-methyl-1H-1,3-benzodiazol-2-yl)(phenyl)methyl]acetamide - CSSB02102334143](/st/structure/200/e5e4154ae222cab5ca406ac1a7e76f16/CN1C%2528C%2528NC%2528%253DO%2529CCl%2529C2%253DCC%253DCC%253DC2%2529%253DNC2%253DCC%253DCC%253DC21.png)
![Chemical structure of tert-butyl N-[(1-methyl-1H-1,3-benzodiazol-2-yl)(phenyl)methyl]carbamate - CSSB00025946271](/st/structure/200/e233aba433c27f50fff06cfb2c61ab03/CN1C%2528%253DNC2%253DCC%253DCC%253DC12%2529C%2528NC%2528%253DO%2529OC%2528C%2529%2528C%2529C%2529C1%253DCC%253DCC%253DC1.png)
![Chemical structure of N-[(1-methyl-1H-1,3-benzodiazol-2-yl)methyl]prop-2-enamide - CSSB00038111745](/st/structure/200/b9819e39880077b820102da197d31364/CN1C%2528CNC%2528%253DO%2529C%253DC%2529%253DNC2%253DCC%253DCC%253DC12.png)
![Chemical structure of N-[(1-methyl-1H-1,3-benzodiazol-2-yl)(phenyl)methyl]ethene-1-sulfonamide - CSSB06713687301](/st/structure/200/d858c618234ed396ee0389a6fca807b8/C%253DCS%2528%253DO%2529%2528%253DO%2529NC%2528C1%253DCC%253DCC%253DC1%2529C1%253DNC2%253DC%2528C%253DCC%253DC2%2529N1C.png)
![Chemical structure of N-{1-[1-(propan-2-yl)-1H-1,3-benzodiazol-2-yl]ethyl}prop-2-enamide - CSSB00103776767](/st/structure/200/edbbd1391bbc21def11344930baec6f9/CC%2528C%2529N1C%2528%253DNC2%253DCC%253DCC%253DC12%2529C%2528C%2529NC%2528%253DO%2529C%253DC.png)
